{
    "laboratory_examinations": [
        {
            "procedure_name": "Growth Hormone Stimulation Tests",
            "date": "Not specified",
            "findings": "Patient II:1 had low peak levels of GH during sleep (3.2 ng/ml) and an arginine stimulation test (2.4 ng/ml).",
            "changes_over_time": "At retesting off GH at 16.6 yr, peak GH levels to arginine and exercise were 5.8 and 2 ng/ml. Further assessment at age 21 yr showed a normal peak GH level of 12.3 ng/ml."
        },
        {
            "procedure_name": "IGF-I Measurement",
            "date": "Age 25 yr",
            "findings": "Low IGF-I level at 101 ng/ml (normal range 127â€“360 ng/ml; -3.1 SDS).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "GH Level Testing",
            "date": "Not specified",
            "findings": "GH-E32A produced significantly increased amounts of 17.5-kDa GH isoform (55% of total GH protein) compared with wt-GH.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Glucagon Stimulation Test",
            "date": "Age 21 yr",
            "findings": "Normal peak GH level of 12.3 ng/ml.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Height and Weight Measurements",
            "date": "Not specified",
            "findings": "Height SDS for Patient II:1 was -5.9 showing significant short stature.",
            "changes_over_time": "Patient II:1 had catch-up growth initially but subsequently had poor compliance with treatment."
        }
    ]
}